Saitama

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Childhood cancers5 trials
• Heart failure3 trials
• Chronic myeloid leukaemia2 trials
• Acute lymphoblastic leukaemia1 trial
• Aplastic anaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• High blood pressure1 trial
• Lung cancer1 trial
• Multiple sclerosis1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Completed7 trials
• Recruiting5 trials

Lead sponsor

• Novartis Pharmaceuticals12 trials

Running trials

• Recruiting

  Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  NCT07354074· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Recruiting

  Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

  NCT06659393· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Recruiting

  Revolade Tablets Specified Drug-use Survey

  NCT06287268· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Recruiting

  Special Drug Use-results Surveillance of Tafinlar/Mekinist

  NCT06262919· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Recruiting

  Study of Out of Specification for Tisagenlecleucel

  NCT04094311· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Aplastic anaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Heart failure1 recruiting

Closed trials

• Completed

  A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study

  NCT06149104· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use Surveillance of Entresto Tablets (Hypertension)

  NCT05976230· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use-results Surveillance of Scemblix Tablets

  NCT05421091· Novartis Pharmaceuticals· Source

• Completed

  Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

  NCT04940065· Novartis Pharmaceuticals· Source

• Completed

  Special Drug Use-results Surveillance of Tabrecta Tablets

  NCT04575025· Novartis Pharmaceuticals· Source

• Completed

  Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

  NCT03774082· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

  NCT03785405· Phase 3· Novartis Pharmaceuticals· Source